They concluded that ischemic stroke patients evaluated in a designated facility were seen by physicians twice as quickly once they reached the hospital, head CTs were performed twice as rapidly for appropriate tPA candidates, and use of tPA more than doubled without any increase in protocol violations or complications. The gene discussed is PLAT; the disease is ischemic stroke.